Phio Pharmaceuticals Corp (PHIO) — Working Capital to Net Assets Ratio
Phio Pharmaceuticals Corp (PHIO) has a Working Capital to Net Assets ratio of 104.1% as of March 2026. Working capital of $17.14 Million (current assets of $17.40 Million minus current liabilities of $260.00K) is measured against net assets of $16.46 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Phio Pharmaceuticals Corp balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Phio Pharmaceuticals Corp Working Capital to Net Assets (2011–2025)
This chart shows how Phio Pharmaceuticals Corp's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 104.1%, reflecting working capital of $17.14 Million against net assets of $16.46 Million USD. Check PHIO goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Phio Pharmaceuticals Corp (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Phio Pharmaceuticals Corp from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Phio Pharmaceuticals Corp.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 104.4% | $21.04 Million | $20.15 Million | $21.48 Million | $435.00K | ▲ +4.5 pp |
| 2024 | 100.0% | $4.72 Million | $4.72 Million | $5.74 Million | $1.01 Million | ▲ +0.5 pp |
| 2023 | 99.5% | $7.69 Million | $7.73 Million | $9.32 Million | $1.63 Million | ▲ +2.5 pp |
| 2022 | 96.9% | $10.51 Million | $10.84 Million | $12.45 Million | $1.94 Million | ▼ -1.8 pp |
| 2021 | 98.8% | $21.66 Million | $21.93 Million | $24.73 Million | $3.07 Million | ▼ -0.9 pp |
| 2020 | 99.6% | $12.97 Million | $13.02 Million | $15.16 Million | $2.20 Million | ▲ +5.3 pp |
| 2019 | 94.3% | $5.42 Million | $5.75 Million | $7.30 Million | $1.88 Million | ▼ -4.4 pp |
| 2018 | 98.7% | $13.41 Million | $13.58 Million | $15.15 Million | $1.74 Million | ▲ +13.2 pp |
| 2017 | 85.5% | $1.57 Million | $1.83 Million | $3.83 Million | $2.27 Million | ▼ -11.8 pp |
| 2016 | 97.3% | $10.56 Million | $10.86 Million | $13.11 Million | $2.54 Million | ▼ -0.6 pp |
| 2015 | 98.0% | $8.71 Million | $8.89 Million | $10.98 Million | $2.27 Million | ▼ -180.9 pp |
| 2014 | 278.8% | $7.65 Million | $2.75 Million | $8.99 Million | $1.33 Million | ▲ +22.5 pp |
| 2013 | 256.3% | $12.67 Million | $4.94 Million | $14.74 Million | $2.08 Million | ▲ +319.9 pp |
| 2012 | -63.6% | $3.71 Million | $-5.84 Million | $5.39 Million | $1.68 Million | ▼ -138.0 pp |
| 2011 | 74.4% | $-437.00K | $-587.00K | $1.34 Million | $1.78 Million | — |